Proven Medicines. Improved Delivery.

At Wilmington Pharmaceuticals, we develop patient-friendly, fast-dissolving formulations for established medicines. Thanks to exclusive licensing agreements and a unique networking environment, we achieve rapid commercialization and FDA approval. Our points of differentiation provide you with an ideal development partner.

• Tightly defined development programs match large therapeutic areas of pain management, CNS and cardiovascular with Zydis® technology—the gold standard of fast-dissolve formulations. Zydis delivers improved patient comfort and compliance and enhances physician results
• Our proven 505(b)(2) expertise leads to low-risk, rapid approvals of valuable NDA products
• Our marketing license partners achieve a reliably high return on investment, while delivering important medical advantages to physicians and patients

Please contact Gene Haley, Chief Executive Officer, to discuss how we can work together.